• MacroGenics held its annual shareholder meeting on May 19, 2026.
• Shareholders ratified Ernst & Young LLP as independent registered public accounting firm for fiscal 2026.
• An amendment to the 2023 Equity Incentive Plan was adopted to increase the share reserve by 1.25 million shares.
• Director nominees were elected to serve as Class I directors for three-year terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MacroGenics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001125345-26-000042), on May 20, 2026, and is solely responsible for the information contained therein.